We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Imaxio Announces the First Human Clinical Trial Using IMX313 in Tuberculosis

News   Sep 04, 2013

 
Imaxio Announces the First Human Clinical Trial Using IMX313 in Tuberculosis
 
 
 

RELATED ARTICLES

Stem Cell Transplant Variables That May Help Eradicate HIV

News

Study shows for the first time that stem cell source, time to achieve full replacement of recipient cells with donor cells, and graft-versus-host reactivity might contribute to HIV eradication.

READ MORE

New Findings Cast Light on Lymphatic system, Key Player in Human Health

News

Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

READ MORE

Transplanting More than Stem Cells to Restore Health

News

Using fecal transplants, researchers restored beneficial bacteria in cancer patients who received antibiotics for stem cell transplant procedures.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE